News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

C.R. Bard Release: Upcoming Presentations Related to the Lutonix Drug-Coated Balloon LEVANT 2 Trial


9/27/2013 9:25:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced two upcoming presentations related to the company’s Lutonix Drug-Coated Balloon (DCB) LEVANT 2 Trial.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
C.R. Bard
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES